IGF-2 LR3Understand the science
How Native IGF-II Engages the Insulin Receptor
1 numbered sourceSource years 2026
Peptide bonds join amino acids into chains. Some chains, including the larger insulin-like growth factors, act as signals by fitting against receptors at the cell surface. Native IGF-II is a defined hormone. The catalog label IGF-2 LR3 is unresolved and should not be treated as another name for the native hormone. Research on known IGF-II can explain how this part of the name relates to a biological pathway without identifying the catalog material. [1]
In 2026, Xi Zhang and colleagues reported structures of the insulin receptor bound to three molecules: insulin, IGF-I and IGF-II. They used cryogenic electron microscopy to observe how the receptor was organized when each was bound. The structures showed that the three hormones could use overlapping sites and produce a similar overall receptor arrangement. They also showed differences in how the ligands interacted at particular sites. The authors used those differences to examine how binding at one place might influence binding at another. [1]
This is a finding about molecular shape and interactions. It does not mean that IGF-II has the same strength, timing or effects as insulin in a person. A receptor can have more than one binding partner while responding to them differently. What happens in tissue depends in part on the amount of each molecule present, what else binds it and which receptors the cells express. [1]
For the unresolved label, the implication is straightforward: a structure obtained with native IGF-II cannot be used to predict how an unspecified variant binds. The study gives a comparison for clearly identified hormones. It leaves any claim about receptor behavior of IGF-2 LR3 untested. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
